Guangzheng Eye Hospital Group Co., Ltd.
Symbool: 002524.SZ
SHZ
4.16
CNYMarktprijs vandaag
211.9824
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
2.12B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Guangzheng Eye Hospital Group Co., Ltd. (002524-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 307.1 | 91.1 | 65.4 | 89.3 | |||||||||||||||||
balance-sheet.row.short-term-investments | -143.74 | 0 | -68 | 31 | |||||||||||||||||
balance-sheet.row.net-receivables | 782.74 | 190.2 | 143.5 | 192.1 | |||||||||||||||||
balance-sheet.row.inventory | 151.98 | 29.6 | 57.3 | 53.2 | |||||||||||||||||
balance-sheet.row.other-current-assets | 23.34 | 5.6 | 3.3 | 5.9 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1265.15 | 316.5 | 269.5 | 340.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2511.93 | 619.7 | 687.6 | 744.2 | |||||||||||||||||
balance-sheet.row.goodwill | 1511.56 | 377.3 | 378.5 | 517.2 | |||||||||||||||||
balance-sheet.row.intangible-assets | 159.62 | 40 | 37 | 55.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1671.19 | 417.2 | 415.5 | 572.8 | |||||||||||||||||
balance-sheet.row.long-term-investments | 181.47 | 0 | 94 | 7.2 | |||||||||||||||||
balance-sheet.row.tax-assets | 182.98 | 49.7 | 40.6 | 40.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 376.81 | 146.3 | 50.2 | 123.6 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 4924.38 | 1232.9 | 1288 | 1488.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.account-payables | 1052.98 | 261.3 | 275.5 | 262.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 1503.14 | 383.2 | 360.8 | 289 | |||||||||||||||||
balance-sheet.row.tax-payables | 63.8 | 16 | 10.9 | 15.2 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 2004.97 | 493.8 | 448.9 | 505.7 | |||||||||||||||||
Deferred Revenue Non Current | 13.05 | 0 | 0 | 30 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.33 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 29.31 | 7.7 | 107.5 | 10.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2047.9 | 507.6 | 468.6 | 507.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1693.54 | 417.3 | 448.4 | 475.7 | |||||||||||||||||
balance-sheet.row.total-liab | 5054.77 | 1263.5 | 1282.7 | 1487.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 2068.45 | 518 | 515.4 | 516.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | -1219.92 | -299.7 | -308.4 | -214.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 200.82 | 0 | 46.5 | 16.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.22 | 65 | 19.6 | 21.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1123.57 | 283.3 | 273.1 | 340.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 11.18 | 2.6 | 1.7 | 0.8 | |||||||||||||||||
balance-sheet.row.total-equity | 1134.75 | 285.9 | 274.8 | 341.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6189.53 | - | - | - | |||||||||||||||||
Total Investments | 75.6 | 19.1 | 26 | 38.2 | |||||||||||||||||
balance-sheet.row.total-debt | 3508.11 | 877 | 809.7 | 794.7 | |||||||||||||||||
balance-sheet.row.net-debt | 3201.01 | 785.9 | 744.3 | 736.4 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 18.29 | -77.8 | 36.4 | 32.1 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | -23.36 | 100 | 106.4 | 62.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | -3.08 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0.15 | 2.5 | 6 | 13.1 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -108.9 | 27.9 | 32.8 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 48.7 | -23.6 | 28.8 | ||||||||||||||||
cash-flows.row.inventory | 0 | -8.7 | 16.9 | -3.9 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -146.7 | 35.8 | 18.8 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 39.32 | 210.7 | -30.1 | 25.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 31.18 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.acquisitions-net | 25.73 | 1.8 | 83.9 | 194.5 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -25.73 | -116.4 | -262.1 | -543 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4.07 | 54.7 | 228.4 | 33.9 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.92 | 0 | 3.5 | 7.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -6.23 | -100.6 | 1.2 | -369.6 | ||||||||||||||||
cash-flows.row.debt-repayment | -170.2 | -232 | -467 | -130.7 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.1 | 22.7 | 29.5 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3.1 | -22.7 | -29.5 | ||||||||||||||||
cash-flows.row.dividends-paid | -15.3 | -11.9 | -16.5 | -46.6 | ||||||||||||||||
cash-flows.row.other-financing-activites | 68.2 | 232.2 | 273.7 | 255.3 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -53.06 | -11.8 | -209.8 | 78 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -3.24 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -29.13 | 12 | -63.2 | -136.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 255.13 | 57 | 45 | 108.3 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 284.26 | 45 | 108.3 | 244.8 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 31.18 | 124.3 | 145.4 | 155 | ||||||||||||||||
cash-flows.row.capital-expenditure | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.free-cash-flow | 9.46 | 83.6 | 92.9 | 92.9 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1058.07 | 1074.9 | 767.4 | 1044.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 689.43 | 697.9 | 575.9 | 709.2 | |||||||||||||||||
income-statement-row.row.gross-profit | 368.64 | 377 | 191.5 | 335.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 5.26 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 37.86 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 337.23 | 328.7 | 281.5 | 334.3 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1026.66 | 1026.6 | 857.4 | 1043.5 | |||||||||||||||||
income-statement-row.row.interest-income | 0.76 | 0.7 | 0.8 | 0.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 40.76 | 100.3 | 100 | 106.4 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 35.43 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -5.32 | 7 | 98.6 | 77 | |||||||||||||||||
income-statement-row.row.income-before-tax | -5.28 | 7.9 | -75.6 | 44.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -3.23 | -1.8 | 2.2 | 8.5 | |||||||||||||||||
income-statement-row.row.net-income | -1.62 | 9.3 | -77.8 | 36.9 |
Vaak gestelde vragen
Wat is Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) totale activa?
Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) totale activa is 1549365088.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 447607126.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.351.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.009.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.007.
Wat is Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) nettowinst (netto-inkomen)?
De nettowinst is 9255045.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 877008780.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 328663038.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 65054312.000.